NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
1-{[4-(1,4,8,11-tetraazacyclotetradecan-1-ylmethyl)phenyl]methyl}-1,4,8,11-tetraazacyclotetradecane hydrate octahydrochloride
|
|
|
IUPAC Traditional name
|
plerixafor hydrate octahydrochloride
|
|
|
Synonyms
|
1,1′-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride
|
JM3100
|
Plerixafor
|
SID791
|
AMD3100 octahydrochloride hydrate
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
H Acceptors
|
8
|
H Donor
|
6
|
LogD (pH = 5.5)
|
-14.815253
|
LogD (pH = 7.4)
|
-9.746932
|
Log P
|
-0.43359208
|
Molar Refractivity
|
155.0134 cm3
|
Polarizability
|
61.66723 Å3
|
Polar Surface Area
|
78.66 Å2
|
Rotatable Bonds
|
4
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
A5602
|
Frequently Asked Questions Live Chat and Frequently Asked Questions are available for this Product. Biochem/physiol Actions AMD3100 is a highly specific chemokine receptor CXCR4 antagonist. Application AMD3100 is a highly specific chemokine receptor CXCR4 antagonist. AMD3100 has been used in a study to determine the blockade of CXCR4 in oral squamous cell carcinoma and inhibition of lymph node metastases. |
PATENTS
PATENTS
PubChem Patent
Google Patent